We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.67B
AUM Growth
+$159M
(+11%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$24.9M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$17.7M |
| 3 |
Alphatec Holdings
ATEC
|
+$15.5M |
| 4 |
Insmed
INSM
|
+$12.9M |
| 5 |
Relay Therapeutics
RLAY
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prothena Corp
PRTA
|
+$31.4M |
| 2 |
CareDx
CDNA
|
+$25.2M |
| 3 |
BioXcel Therapeutics
BTAI
|
+$15.5M |
| 4 |
Maravai LifeSciences
MRVI
|
+$11.2M |
| 5 |
Health Catalyst
HCAT
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.7% |
| 2 | Communication Services | 4.44% |
| 3 | Energy | 0.19% |
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.
- First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
- First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
- First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
- First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
- First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
- First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
- First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.
Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.